Literature DB >> 1314770

Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma.

A Eguchi1, O Nakashima, S Okudaira, S Sugihara, M Kojiro.   

Abstract

The nodular lesions seen in the noncancerous areas of the 80 consecutively resected small hepatocellular carcinoma associated with cirrhosis were pathomorphologically studied. A total of 51 nodular lesions were found, and they were classified into the following four groups: large regenerative nodule (30 nodules), adenomatous hyperplasia (12 nodules), atypical adenomatous hyperplasia (4 nodules) and adenomatous hyperplasia containing cancerous foci (5 nodules). Grossly, all large regenerative nodules were well demarcated, but some of the adenomatous hyperplasia group were vaguely nodular. Atypical adenomatous hyperplasia and adenomatous hyperplasia containing cancerous foci accounted for 43% of the adenomatous hyperplasia group found in the vicinity of the 16 resected hepatocellular carcinoma (20%) out of 80 cases. The mean size (+/- S.D.) of the adenomatous hyperplasias containing cancerous foci, 15.8 +/- 2.2 mm, was significantly larger than 10.1 +/- 2.6 mm of the adenomatous hyperplasias p less than 0.01). All adenomatous hyperplasias containing cancerous foci and 75% of the atypical adenomatous hyperplasias demonstrated a marked fatty change, but none of the large regenerative nodules were accompanied by any fatty changes. This study demonstrated the morphological transition from adenomatous hyperplasia to hepatocellular carcinoma that was suggestive of multistep hepatocarcinogenesis. As a result, it is predicted that approximately 20% of all hepatocellular carcinomas may have the potential for being of multicentric origin and that approximately 40% of adenomatous hyperplasias may undergo malignant transformation, but it is difficult to estimate the exact number of incidences. The presence of varying degrees of fatty change may be one of the significant morphological markers for a malignant transformation from adenomatous hyperplasia to hepatocellular carcinoma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1314770     DOI: 10.1002/hep.1840150516

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

1.  The value of in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging.

Authors:  H Xu; D Jiang; L Yang; Y Xiong; F Yang; X Kong
Journal:  J Tongji Med Univ       Date:  2000

2.  Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients.

Authors:  Sith Phongkitkarun; Kuruwin Limsamutpetch; Penampai Tannaphai; Janjira Jatchavala
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

3.  Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Yukihisa Takayama; Nobuhiro Fujita; Yuichiro Kubo; Shinichi Aishima; Ken Shirabe; Takashi Yoshiura; Hiroshi Honda
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

4.  Comparison of the proliferative capacity of adenomatous hyperplasia and well differentiated hepatocellular carcinoma.

Authors:  A Yamashita
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

Review 5.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Enzymatic cytochemistry, DNA ploidy and AgNOR quantitation in hepatocellular nodules of uncertain malignant potential in liver cirrhosis.

Authors:  L Bolondi; L Gramantieri; P Chieco; C Melchiorri; D Treré; B Stecca; M Derenzini; L Barbara
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

7.  Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.

Authors:  Matthew M Yeh; Hubert Darius-J Daniel; Michael Torbenson
Journal:  Mod Pathol       Date:  2009-11-20       Impact factor: 7.842

8.  Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers.

Authors:  T Terada; K Ueda; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Small (< or = 3 cm) hepatic lesions. Results of sonographically guided fine-needle biopsy in 385 patients.

Authors:  F Fornari; C Filice; G L Rapaccini; E Caturelli; L Cavanna; G Civardi; M Di Stasi; E Buscarini; L Buscarini
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

10.  Adenomatous hyperplasia of the liver resembling focal nodular hyperplasia in patients with chronic liver disease.

Authors:  T Terada; S Kitani; K Ueda; Y Nakanuma; K Kitagawa; S Masuda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.